Clovis Oncology is a commercial-stage biotechnology company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the United States, Europe, and other international markets. The company's approach to precision medicine aims to deliver the right drug to the right patient at the right time, targeting specific subsets of cancer. Clovis develops diagnostic tools in collaboration with partners to direct compounds to patients most likely to benefit.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account